Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Altimmune

Start price
Target price
Perf. (%)
€5.09
12.12.23
-
12.12.24
30.56%
13.05.24

Could be worthwhile Investment >10% per year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€43.80
26.12.23
-
26.12.24
32.42%
13.05.24

Could be very worthwhile Investment >20% year
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€1.99
07.01.24
-
07.01.25
22.24%
13.05.24

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.53
28.04.24
-
28.04.25
17.56%
13.05.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.83
28.04.24
-
28.04.25
8.96%
13.05.24

buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.43
28.04.24
-
28.04.25
11.19%
13.05.24

buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€2.60
09.05.24
-
09.05.25
-29.60%
13.05.24

Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€4.30
02.05.24
-
02.05.25
-57.47%
13.05.24

buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€881.20
12.05.23
€915.90
12.05.24
6.95%
13.05.24

buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€881.20
12.05.23
€915.90
12.05.24
6.95%
13.05.24

buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€881.20
12.05.23
€915.90
12.05.24
6.95%
13.05.24

buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€81.98
12.05.23
-
12.05.24
-1.24%
13.05.24

buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€418.10
03.05.24
€425.00
03.05.25
5.41%
12.05.24

Market Leader or Top 3
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€418.10
03.05.24
€425.00
03.05.25
5.41%
12.05.24

Market Leader or Top 3
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€418.10
03.05.24
€425.00
03.05.25
5.41%
12.05.24

Market Leader or Top 3
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€3.81
07.05.24
-
07.05.25
-51.97%
12.05.24

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.37
10.05.24
-
10.05.25
-27.99%
12.05.24

Risky Investment
Novavax Inc.

Start price
Target price
Perf. (%)
€9.37
10.05.24
-
10.05.25
-7.12%
12.05.24

buy
Arista Networks

Start price
Target price
Perf. (%)
€266.90
02.03.24
€266.00
02.03.25
9.12%
12.05.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€4.42
03.05.24
€4.00
03.05.25
96.81%
12.05.24

buy
American Water Works Corp. Inc.

Start price
Target price
Perf. (%)
€120.40
17.11.23
€122.00
17.11.24
4.71%
12.05.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.45
19.02.24
€0.000
19.02.25
-63.24%
12.05.24